Patent · US Active

Inhibitors of TYK2

US12358904B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 3, 2024
Grant dateJul 15, 2025
Priority date
Expiry dateJun 3, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65583
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In exemplary embodiments, inhibitors of Tyrosine Kinase 2 (TYK2), pharmaceutical formulations comprising these compounds, methods of using these compounds to inhibit TYK2, and treat diseases such as autoimmune and inflammatory diseases are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.